Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
Journal of the American College of Cardiology|November 11, 2025
Danicamtiv, a Selective Agonist of Cardiac Myosin, for Dilated Cardiomyopathy: A Phase 2 Open-Label TrialNeal K Lakdawala, Ray E Hershberger, Pablo Garcia-Pavia, et al.
European Heart Journal|August 28, 2023
Emery-Dreifuss muscular dystrophy Type 1 is associated with a high risk of malignant ventricular arrhythmias and end-stage heart failureDouglas E Cannie, Petros Syrris, Alexandros Protonotarios, et al.
European Journal of Human Genetics : EJHG|January 8, 2026
Domain-specific phenotypic profiles in RAF1-related Noonan syndromeAndrea Gazzin, Marta Calvo, Federico Rondot, et al.
Circulation. Genomic and Precision Medicine|August 18, 2023
Risks of Ventricular Arrhythmia and Heart Failure in Carriers of RBM20 VariantsDouglas E Cannie, Alexandros Protonotarios, Athanasios Bakalakos, et al.
Plos One|September 29, 2025
Statin effect on arrhythmogenic cardiomyopathy disease progression (SEARCH): Randomized clinical study protocolElena Sommariva, Melania Lippi, Flavia Bruttini, et al.
European Heart Journal|June 29, 2022
Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculatorAlexandros Protonotarios, Riccardo Bariani, Chiara Cappelletto, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|May 2, 2025
NAXCARE: a clinical outcome registry for Naxos disease and related cardiocutaneous syndromesAdalena Tsatsopoulou, Dominic Jr Abrams, Aris Anastasakis, et al.
Circulation|January 5, 2026
Clinical Spectrum of Children With Parvovirus B19-Associated Acute MyocarditisEnrico Ammirati, Giacomo Veronese, Francesca Raimondi, et al.
European Journal of Heart Failure|November 29, 2025
Clinical phenotype and prognosis of real-world patients with wild-type transthyretin amyloid cardiomyopathy treated with tafamidisAldostefano Porcari, Paolo Milani, Simone Longhi, et al.
Pageof 15